Pricing Log in Create free account

Milestone Pharmaceuticals Inc. (MIST) vs Tenaya Therapeutics, Inc. (TNYA)

Milestone Pharmaceuticals Inc. and Tenaya Therapeutics, Inc. are both Biotechnology companies. Milestone Pharmaceuticals Inc. and Tenaya Therapeutics, Inc. are of similar size ($84.5M and $82.4M). Tenaya Therapeutics, Inc. has the higher net margin (0.00% vs −1,586.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Tenaya Therapeutics, Inc. leads on 8 and Milestone Pharmaceuticals Inc. on 5.

Valuation

Metric MIST TNYA Biotechnology median
P/E n/m n/m 10.96
P/S 18.07 n/m 9.52
P/B 5.25 1.58 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA 0.20 n/m 0.68
EV/Sales (2.96) n/m 9.00
Earnings yield (100.00%) (129.95%) (32.09%)
Free cash flow yield (64.42%) (63.60%) (22.62%)

Profitability

Metric MIST TNYA Biotechnology median
Gross margin 13.27% 0.00% 68.51%
Operating margin (1,479.69%) 0.00% 0.00%
Net margin (1,586.01%) 0.00% 0.00%
Free cash flow margin (1,163.79%) 0.00% 0.00%
Return on equity (35,522.62%) (148.16%) (50.12%)
Return on assets (73.36%) (112.05%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MIST TNYA Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) (11.94%) 54.96% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MIST TNYA Biotechnology median
Debt to equity 3.25 0.00 0.00
Current ratio 8.13 3.78 4.74
Net debt to EBITDA 0.79 1.19 1.01

Dividend

Metric MIST TNYA Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric MIST TNYA Biotechnology median
Market cap 82.44m 84.47m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack